Pfizer’s antibody pact with Nona Biosciences; Epkinly’s label expansionnews2025-11-19T14:45:01+00:00November 19th, 2025|Endpoints News|
GSK picks LTZ Therapeutics in myeloid cell engager pact worth $50M upfrontnews2025-11-19T11:58:05+00:00November 19th, 2025|Endpoints News|
Alkermes ups bid for Avadel after Lundbeck tried snatching narcolepsy biotechnews2025-11-19T11:52:06+00:00November 19th, 2025|Endpoints News|
Nabla Bio announces AI antibody model update in JAM-2news2025-11-19T10:00:53+00:00November 19th, 2025|Endpoints News|
New report suggests America must wean off China APIsnews2025-11-18T20:37:33+00:00November 18th, 2025|Endpoints News|
Senator questions Lilly CEO on details of Trump deal for weight loss drugsnews2025-11-18T20:16:32+00:00November 18th, 2025|Endpoints News|
Makary calls for ‘America First’ drug user fee renegotiationsnews2025-11-18T19:14:27+00:00November 18th, 2025|Endpoints News|
Arrowhead gets FDA approval for rare lipid disease drugnews2025-11-18T18:52:23+00:00November 18th, 2025|Endpoints News|
SixPeaks CEO talks about $170M sale to AstraZeneca and what comes next in obesitynews2025-11-18T15:47:23+00:00November 18th, 2025|Endpoints News|
Merck, Bristol Myers disclose layoffs in New Jerseynews2025-11-18T15:12:17+00:00November 18th, 2025|Endpoints News|
